06.10.2021 14:46:33
|
Moderna Launches Fellowship Program For Young Researchers Of MRNA Medicines - Quick Facts
(RTTNews) - Biotechnology company Moderna, Inc. (MRNA) announced Wednesday the launch of the Moderna Fellowship Program. The goal of the program is to support the next generation of scientists and healthcare professionals as they innovate in the field of mRNA research towards improving patient care and population health.
Prospective fellows may be clinicians and scientists who are interested in advancing mRNA research and innovation and the program underpins Moderna's commitment to supporting independent research.
The fellowship program will select approximately 50 global fellows in the first year with a focus on infectious diseases. Greg Poland, M.D., infections disease expert and Director of Mayo Clinic's Vaccine Research Group, will serve as Chair of the program.
The fellowship program will be overseen by an independent steering committee of international experts in science, medicine, and healthcare. The committee expects to receive applications from institutions around the world who wish to appoint a fellow in either clinical medicine, scientific research or another healthcare related discipline.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Moderna Incmehr Nachrichten
24.01.25 |
Freitagshandel in New York: S&P 500 zum Start fester (finanzen.at) | |
23.01.25 |
S&P 500-Handel aktuell: S&P 500 beendet den Donnerstagshandel mit Gewinnen (finanzen.at) | |
23.01.25 |
Gute Stimmung in New York: So steht der S&P 500 am Nachmittag (finanzen.at) | |
23.01.25 |
S&P 500-Titel Moderna-Aktie: So viel Verlust wäre bei einem Investment in Moderna von vor 3 Jahren angefallen (finanzen.at) | |
22.01.25 |
Freundlicher Handel in New York: S&P 500 schließt in der Gewinnzone (finanzen.at) | |
22.01.25 |
Freundlicher Handel in New York: S&P 500-Anleger greifen zu (finanzen.at) | |
22.01.25 |
S&P 500-Handel aktuell: S&P 500 verbucht am Mittag Gewinne (finanzen.at) | |
22.01.25 |
S&P 500 aktuell: S&P 500-Börsianer greifen zum Handelsstart zu (finanzen.at) |
Analysen zu Moderna Incmehr Analysen
19.11.24 | Moderna Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
05.08.24 | Moderna Sector Perform | RBC Capital Markets | |
12.01.24 | Moderna Outperform | RBC Capital Markets | |
03.11.23 | Moderna Buy | Goldman Sachs Group Inc. |
Aktien in diesem Artikel
Moderna Inc | 43,14 | 8,87% |